Judge weighs “fairness” of $7.25 billion Roundup settlement for cancer victims
Opposing teams of attorneys spent hours on Monday battling over a proposed $7.25 billion settlement of the US Roundup cancer litigation that, if approved, would allow Bayer to keep selling its controversial glyphosate weed killers while providing roughly $10,000 to $165,000 for individuals suffering from cancer they blame on Roundup use.
IN-DEPTH
Cancer in the Corn Belt Exploring evidence linking Iowa agriculture to public health problems
Paraquat Papers Syngenta records reveal corporate secrets surrounding paraquat.
Poison PR Inside a pesticide industry campaign to silence critics.
Your donation powers fearless reporting and helps us hold the powerful accountable — give today.
Receive the latest news and environmental insights.
